| Original language | English |
|---|---|
| Pages (from-to) | 1-12 |
| Number of pages | 12 |
| Journal | Clinical Advances in Hematology and Oncology |
| Volume | 23 |
| Issue number | 9 |
| State | Published - Dec 1 2025 |
Fingerprint
Dive into the research topics of 'Ravulizumab-danicopan combination therapy in PNH management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver